tizanidine

Generic: tizanidine

Labeler: northwind health company, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler northwind health company, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
Northwind Health Company, LLC

Identifiers & Regulatory

Product NDC 51655-740
Product ID 51655-740_495152d8-6067-6142-e063-6394a90ae6b0
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076416
Listing Expiration 2027-12-31
Marketing Start 2022-09-23

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51655740
Hyphenated Format 51655-740

Supplemental Identifiers

RxCUI
313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA076416 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE, PLASTIC (51655-740-26)
  • 30 TABLET in 1 BOTTLE, PLASTIC (51655-740-52)
  • 15 TABLET in 1 BOTTLE, PLASTIC (51655-740-54)
source: ndc

Packages (3)

51655-740-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-740-26) 51655-740-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-740-52) 51655-740-54 15 TABLET in 1 BOTTLE, PLASTIC (51655-740-54)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Tizanidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "495152d8-6067-6142-e063-6394a90ae6b0", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313413"], "spl_set_id": ["f32f399f-42af-f0ba-e053-2a95a90a8c2e"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (51655-740-26)", "package_ndc": "51655-740-26", "marketing_start_date": "20221007"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-740-52)", "package_ndc": "51655-740-52", "marketing_start_date": "20220926"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE, PLASTIC (51655-740-54)", "package_ndc": "51655-740-54", "marketing_start_date": "20220923"}], "brand_name": "Tizanidine", "product_id": "51655-740_495152d8-6067-6142-e063-6394a90ae6b0", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "51655-740", "generic_name": "Tizanidine", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076416", "marketing_category": "ANDA", "marketing_start_date": "20220923", "listing_expiration_date": "20271231"}